Strep Throat in Children: Antibiotic Choice and Dosing
Group A streptococcal (GAS) pharyngitis — commonly called strep throat — is one of the most frequent reasons a child receives an antibiotic prescription. Choosing the right strep throat children antibiotic regimen matters: correct drug selection and dosing shortens symptoms, prevents suppurative complications, and reduces the already-low risk of acute rheumatic fever (ARF). This guide walks through current Infectious Diseases Society of America (IDSA) and American Academy of Pediatrics (AAP) recommendations, practical dosing tables, penicillin-allergy alternatives, and the questions parents most often ask.
TL;DR
- First-line treatment is oral amoxicillin 50 mg/kg once daily (max 1 000 mg) or 25 mg/kg twice daily (max 500 mg/dose) for 10 days.
- Penicillin V remains equally effective but is less palatable; a single IM benzathine penicillin G injection is an alternative when adherence is a concern.
- For confirmed penicillin allergy, first-generation cephalosporins (cephalexin) are preferred if the reaction was not anaphylaxis; azithromycin is reserved for IgE-mediated allergy.
- Test before treating: rapid antigen detection test (RADT) or throat culture should confirm GAS before antibiotics are prescribed — empiric therapy is discouraged.
- Children can return to school after 12–24 hours of effective antibiotic therapy plus improvement in symptoms and absence of fever.
What Is GAS Pharyngitis?
Group A Streptococcus pyogenes (GAS) is a gram-positive bacterium responsible for the vast majority of bacterial pharyngitis in school-age children. Viral causes account for the majority of sore throats overall, but GAS is implicated in roughly 20–30 % of pharyngitis episodes in children aged 5–15 years, compared with only 5–15 % in adults.
Why It Matters
Untreated GAS pharyngitis carries a small but real risk of:
- Suppurative complications — peritonsillar abscess, retropharyngeal abscess, cervical lymphadenitis, mastoiditis.
- Non-suppurative sequelae — acute rheumatic fever (ARF), post-streptococcal glomerulonephritis (PSGN). ARF is rare in high-income countries but remains a significant public health concern globally.
- Transmission — GAS spreads readily through respiratory droplets and close contact, making school and daycare settings high-risk environments.
Seasonal peaks occur in late winter and early spring in temperate climates. Children younger than 3 years rarely develop classic strep pharyngitis and are at very low risk for ARF; testing in this age group is generally not recommended unless specific risk factors are present.
Diagnosis: Test-and-Treat, Not Empiric Therapy
The IDSA/AAP guideline is explicit: do not prescribe antibiotics for pharyngitis without microbiological confirmation of GAS. Clinical scoring systems (e.g., the modified Centor or McIsaac score) can help prioritize who to test, but they are not sufficiently specific to replace laboratory confirmation.
Recommended Diagnostic Approach
| Step | Action | Notes |
|---|---|---|
| 1 | Clinical assessment | Sudden onset of sore throat, fever ≥ 38.3 °C, tonsillar exudates, tender anterior cervical lymph nodes, absence of cough/rhinorrhea suggest GAS |
| 2 | Rapid antigen detection test (RADT) | Specificity > 95 %; sensitivity 70–90 % depending on the assay |
| 3 | Backup throat culture (children/adolescents) | If RADT is negative in a child with high clinical suspicion, a throat culture should be obtained; IDSA recommends this because of the lower sensitivity of some RADTs |
| 4 | Treat only confirmed positives | Do not prescribe antibiotics while awaiting culture results unless clinical urgency dictates otherwise |
NICE (NG84) takes a somewhat more conservative stance in the UK setting, recommending a delayed or no-antibiotic strategy for most sore throats, with immediate antibiotics reserved for patients who are systemically very unwell, have signs of suppurative complications, or are at high risk for complications. The FeverPAIN and Centor scores inform the decision to test or treat in the UK pathway.
Key point: Overtreating viral pharyngitis with antibiotics contributes to antimicrobial resistance, exposes children to unnecessary side effects, and does not improve outcomes. Testing first protects individual patients and public health.
First-Line Antibiotics: Amoxicillin and Penicillin
Penicillin (or its better-tasting relative, amoxicillin) has remained the recommended first-line agent for GAS pharyngitis for over six decades. No clinical isolate of GAS with confirmed penicillin resistance has ever been reported worldwide — a remarkable track record that underpins the strength of this recommendation.
Why Amoxicillin Over Penicillin V in Practice
- Palatability — Amoxicillin suspension is significantly better tolerated by children than penicillin V liquid.
- Once-daily option — A single daily dose of amoxicillin (50 mg/kg, max 1 000 mg) has been shown to be non-inferior to twice-daily dosing for GAS pharyngitis, which simplifies adherence.
- Equivalent efficacy — Bacteriological and clinical cure rates are comparable between amoxicillin and penicillin V when full courses are completed.
First-Line Dosing Table
| Drug | Formulation | Dose | Frequency | Duration | Max Dose |
|---|---|---|---|---|---|
| Amoxicillin | Suspension (125 mg/5 mL, 250 mg/5 mL) or chewable tabs | 50 mg/kg/day | Once daily | 10 days | 1 000 mg/day |
| Amoxicillin | Suspension or tabs | 25 mg/kg/dose | Twice daily | 10 days | 500 mg/dose |
| Penicillin V | Suspension or tabs | 250 mg (< 27 kg) or 500 mg (≥ 27 kg) | 2–3 times daily | 10 days | 500 mg/dose |
| Benzathine penicillin G | IM injection | 600 000 units (< 27 kg) or 1 200 000 units (≥ 27 kg) | Single dose | — | 1 200 000 units |
The full 10-day course is essential. Shorter courses of penicillin or amoxicillin have been associated with higher bacteriological failure rates and do not reliably prevent ARF. Parents should be counselled that stopping early — even if the child feels better after 2–3 days — risks incomplete eradication and recurrence.
Intramuscular benzathine penicillin G guarantees adherence in a single visit and is particularly useful when follow-through with a 10-day oral course is uncertain (e.g., history of non-adherence, social circumstances, or high ARF-risk populations).
Penicillin Allergy Alternatives
True IgE-mediated penicillin allergy is far less common than reported. Studies consistently show that over 90 % of patients labelled "penicillin allergic" can tolerate penicillins when formally evaluated. Nevertheless, when a documented or plausible allergy exists, the following alternatives are recommended.
Choosing an Alternative Based on Allergy Type
| Allergy Type | Recommended Alternative | Dose | Duration | Notes |
|---|---|---|---|---|
| Non-anaphylactic (rash, GI upset) | Cephalexin | 20 mg/kg/dose twice daily (max 500 mg/dose) | 10 days | First-generation cephalosporin; ~2 % cross-reactivity with penicillins |
| Non-anaphylactic (rash, GI upset) | Cefadroxil | 30 mg/kg once daily (max 1 000 mg) | 10 days | Once-daily dosing improves adherence |
| Anaphylaxis / severe IgE-mediated | Azithromycin | 12 mg/kg once daily (max 500 mg) for day 1, then 6 mg/kg (max 250 mg) days 2–5 | 5 days | GAS macrolide resistance varies by region (5–40 %); check local susceptibility |
| Anaphylaxis / severe IgE-mediated | Clindamycin | 7 mg/kg/dose three times daily (max 300 mg/dose) | 10 days | Alternative when macrolide resistance is high |
- Cephalosporins are preferred over macrolides for non-anaphylactic penicillin allergy because of superior bacteriological eradication rates and lower resistance concerns.
- Azithromycin should not be used as first-line in penicillin-tolerant patients. The convenience of a 5-day course is appealing, but rising macrolide resistance in GAS (reported at 5–40 % in various surveillance studies) undermines its reliability.
- Clindamycin is effective but carries a risk of Clostridioides difficile–associated diarrhea, particularly with prolonged courses.
- Penicillin allergy de-labelling should be considered in children with vague or distant allergy histories. Referral for formal allergy testing (skin prick/intradermal test or graded oral challenge) can safely restore access to first-line therapy.
Side Effects and Monitoring
Antibiotics used for GAS pharyngitis are generally well tolerated in short courses. The most common adverse effects are gastrointestinal.
Common Side Effects by Drug Class
| Drug | Common Side Effects | Less Common but Notable |
|---|---|---|
| Amoxicillin | Diarrhea (3–10 %), nausea, non-allergic rash (~5–10 %, especially if EBV co-infection) | Allergic reactions, C. difficile colitis (rare) |
| Penicillin V | GI upset, diarrhea | Allergic reactions |
| Cephalexin | Diarrhea, nausea | Allergic cross-reactivity with penicillins (~2 %) |
| Azithromycin | Diarrhea, abdominal pain, nausea | QT prolongation (rare at standard doses), hepatotoxicity (very rare) |
| Clindamycin | Diarrhea, nausea, abdominal cramps | C. difficile–associated diarrhea (higher risk than other agents) |
Practical Monitoring Points
- Amoxicillin rash vs allergy: A diffuse, maculopapular, non-pruritic rash appearing several days into amoxicillin therapy — particularly in a child with concurrent Epstein-Barr virus (EBV) infection/mononucleosis — is usually non-allergic and does not predict future penicillin allergy. However, urticaria, angioedema, or any respiratory compromise should be treated as a true allergic reaction.
- Symptom re-evaluation: If a child shows no improvement after 48–72 hours of appropriate therapy, re-assess for alternative diagnoses (peritonsillar abscess, viral pharyngitis with false-positive RADT, or non-pharyngeal sources of fever).
- Probiotics: Some clinicians suggest concurrent probiotics (e.g., Lactobacillus spp.) to reduce antibiotic-associated diarrhea. Evidence is modest but suggests a small benefit with minimal risk.
Special Populations
Children Under 3 Years
Classic GAS pharyngitis is uncommon in children younger than 3 years. In this age group, GAS carriage rates can be high without clinical disease, and the risk of ARF is exceedingly low. The IDSA does not recommend routine testing for GAS pharyngitis in children under 3 unless there is a specific risk factor (e.g., sibling with documented GAS infection, or high-prevalence ARF setting). Nasal discharge, excoriated nares, and low-grade fever ("streptococcal nasopharyngitis") may be the predominant presentation in this age group.
Recurrent GAS Pharyngitis
Recurrent episodes present a management challenge. Possible explanations include:
- New infection from a close contact or environmental source.
- Chronic carrier state with intercurrent viral pharyngitis — the child carries GAS asymptomatically and develops sore throat from a virus, with the positive test reflecting carriage rather than active infection.
- Antibiotic failure — rare with penicillins given universal GAS susceptibility, but poor adherence to 10-day courses is a common contributor.
Management strategies for recurrent strep:
- Confirm each episode microbiologically — do not treat empirically based on symptom pattern alone.
- Ensure adherence — a single dose of IM benzathine penicillin G eliminates the adherence variable.
- Evaluate household contacts — simultaneous testing and treatment of family members or close contacts may interrupt transmission cycles.
- Consider carrier state evaluation — if a child has frequent positive tests but atypical presentations, testing during an asymptomatic period can help determine carrier status.
- Tonsillectomy — the AAP and the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) guideline suggests tonsillectomy may be considered for children meeting the Paradise criteria (≥ 7 episodes in 1 year, ≥ 5/year for 2 years, or ≥ 3/year for 3 years, each documented by culture or RADT). Tonsillectomy reduces but does not eliminate pharyngitis episodes.
Immunocompromised Children
Immunocompromised children with GAS pharyngitis should receive standard first-line therapy, but clinicians should maintain a lower threshold for evaluating complications. Invasive GAS disease, while uncommon, can progress rapidly in this population.
Red Flags — When to Seek Immediate Care
Parents should be advised to seek urgent medical attention if a child with suspected or confirmed strep throat develops any of the following:
- Inability to swallow saliva or significant drooling — may indicate peritonsillar or retropharyngeal abscess
- Severe neck stiffness or swelling (especially unilateral) — possible deep-space neck infection
- Difficulty breathing or stridor — upper airway compromise
- High fever (> 40 °C / 104 °F) persisting beyond 48 hours of appropriate antibiotic therapy
- Signs of dehydration — reduced urine output, no tears, dry mucous membranes, listlessness
- Widespread rash with a sandpaper texture (scarlet fever) — this is not an emergency per se but warrants medical evaluation and confirmation of appropriate antibiotic therapy
- Joint pain or swelling appearing 2–4 weeks after a throat infection — raises concern for ARF
- Dark or cola-coloured urine, facial or periorbital oedema — possible PSGN, typically 1–3 weeks after infection
Any child who appears toxic, is unable to maintain hydration, or is deteriorating despite antibiotics requires same-day evaluation.
Return-to-School and Practical Guidance
Children may return to school or daycare after at least 12 hours of effective antibiotic therapy, provided they are afebrile and feel well enough to participate. Most children experience significant symptom improvement within 24–48 hours of starting antibiotics. The 12-hour minimum is intended to reduce transmission risk — GAS shedding drops dramatically after the first few doses of an effective antibiotic.
Supportive Care Alongside Antibiotics
- Analgesics/antipyretics: Paracetamol (acetaminophen) or ibuprofen at weight-appropriate doses for pain and fever control. Avoid aspirin in children (Reye syndrome risk).
- Hydration: Encourage cool fluids; popsicles and ice chips can soothe throat pain.
- Soft diet: Offer soft, non-acidic foods during the acute phase.
- Throat lozenges and sprays: May be used in older children (generally > 6 years); avoid in young children due to choking risk. Benzocaine-containing products should be avoided in children under 2 years (methemoglobinemia risk).
What Parents Should Know About the Antibiotic Course
- Complete the full course — even if the child feels better after 2–3 days, stopping early risks treatment failure and does not reliably prevent ARF.
- Missed dose — give it as soon as remembered unless it is nearly time for the next dose; do not double up.
- Storage — amoxicillin suspension should be refrigerated and shaken well before each dose. Discard any remaining suspension after 14 days.
Frequently Asked Questions
1. Can strep throat go away without antibiotics?
Yes — GAS pharyngitis is usually self-limiting, and symptoms will typically resolve within 3–5 days even without treatment. However, antibiotics shorten symptom duration by approximately 1–2 days, reduce transmission, prevent suppurative complications, and — most importantly — reduce the risk of acute rheumatic fever. For this reason, all confirmed GAS pharyngitis in children should be treated with antibiotics.
2. Why is a 10-day course necessary when my child feels better in 2 days?
The 10-day duration is specifically validated for eradication of GAS from the pharynx and prevention of ARF. Shorter courses of amoxicillin or penicillin have shown inferior bacteriological cure rates. The 5-day azithromycin course is an exception because of azithromycin's prolonged tissue half-life, but it is reserved for penicillin-allergic patients.
3. Is azithromycin (a "Z-Pack") a good choice for strep throat?
Azithromycin is not first-line for GAS pharyngitis. It should only be used when a child has a confirmed or strongly suspected IgE-mediated penicillin allergy that precludes cephalosporin use. Macrolide resistance in GAS varies regionally (reported at 5–40 % in surveillance data), which can lead to treatment failure. Amoxicillin or penicillin remain the preferred agents.
4. My child keeps getting strep throat — should they have their tonsils removed?
Tonsillectomy may be considered if a child meets the Paradise criteria: ≥ 7 documented episodes in one year, ≥ 5 per year for two consecutive years, or ≥ 3 per year for three consecutive years. Even then, tonsillectomy reduces but does not eliminate pharyngitis episodes. Discuss the benefits, risks, and alternatives with your child's otolaryngologist and paediatrician.
5. Should I keep my child out of school until the full antibiotic course is done?
No. Current guidance allows return to school after at least 12 hours of effective antibiotic therapy, as long as the child is afebrile and feeling well enough to participate. There is no need to complete the full 10-day course before returning.
6. Can my child take amoxicillin if they had a rash with it before?
It depends on the type of rash. A delayed, non-pruritic, maculopapular rash — particularly one that occurred during a concurrent viral illness such as mononucleosis — is usually not a true allergy and does not preclude future use. An urticarial (hive-like) rash, however, may represent a true allergic reaction. Formal allergy evaluation can clarify whether amoxicillin is safe to use again.
7. Do I need to replace my child's toothbrush after strep throat?
This is commonly recommended by parents and some clinicians, but there is no strong evidence that toothbrush replacement reduces recurrence. GAS does not survive well on dry surfaces, and re-infection from a toothbrush is unlikely. That said, replacing the toothbrush is inexpensive and poses no harm, so it remains a reasonable practice if it provides reassurance.
8. Should siblings or household contacts be tested?
Routine testing of asymptomatic household contacts is not recommended by IDSA in most settings. However, if a household member develops symptoms of pharyngitis, they should be tested. In families with recurrent GAS infections, simultaneous testing and treatment of all symptomatic contacts may help interrupt the cycle.
References
-
Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86–e102. PMID: 22965026
-
NICE. Sore throat (acute): antimicrobial prescribing. Guideline NG84. 2018. nice.org.uk/guidance/ng84
-
Spinks A, Glasziou PP, Del Mar CB. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst Rev. 2021;12:CD000023. PMID: 34871949
-
Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association. Circulation. 2009;119(11):1541–1551. PMID: 19246689
-
CDC. Group A streptococcal (GAS) disease — pharyngitis: clinical guidance. 2024. cdc.gov/group-a-strep/hcp/clinical-guidance
-
Lennon DR, Farrell E, Martin DR, Stewart JM. Once-daily amoxicillin versus twice-daily penicillin V in group A β-haemolytic streptococcal pharyngitis. Arch Dis Child. 2008;93(6):474–478. PMID: 18337284
-
Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. 2005;115(4):1048–1057. PMID: 15805383
-
Mitchell RB, Archer SM, Ishman SL, et al. Clinical practice guideline: tonsillectomy in children (update). Otolaryngol Head Neck Surg. 2019;160(1_suppl):S1–S42. PMID: 30798778
-
Wald ER. Group A streptococcal tonsillopharyngitis in children: clinical features and diagnosis. UpToDate. 2024. uptodate.com
-
DailyMed. Amoxicillin — drug label information. National Library of Medicine. dailymed.nlm.nih.gov
About the Author
Dr. Stanislav Ozarchuk, PharmD, is a clinical pharmacist with 15 years of experience in community and hospital pharmacy practice. He specialises in evidence-based medication review, paediatric and geriatric pharmacotherapy, and patient safety. As a contributor to PillsCard.com, Dr. Ozarchuk translates complex pharmacological evidence into clear, actionable guidance for patients, caregivers, and healthcare professionals worldwide.
Medical Disclaimer
This article is intended for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The information presented reflects evidence-based guidelines current at the time of writing but may not account for individual patient circumstances, local resistance patterns, or evolving clinical recommendations. Always consult a qualified healthcare professional — such as your child's paediatrician or pharmacist — before starting, stopping, or changing any medication. Do not delay seeking professional medical advice because of information read on this website. In case of a medical emergency, contact your local emergency services immediately.